This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
WellCare Unit Inks Deal to Serve Medicaid Liver Patients
by Zacks Equity Research
WellCare's (WCG) unit inks a value-based deal to introduce the Hepatitis C Center of Excellence program for check-up and treatment of Medicaid members.
4 Top Stocks Thriving With Beat Potential This Earnings Season
by Sanghamitra Saha
These top-ranked stocks are likely to beat on the bottom line in their next release.
New Strong Buy Stocks for April 16th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
Why the Earnings Surprise Streak Could Continue for Molina (MOH)
by Zacks Equity Research
Molina (MOH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
UnitedHealth's (UNH) Unit to Upgrade Care Bundles Program
by Zacks Equity Research
UnitedHealth's (UNH) arm to offer better care with its enhanced UnitedHealthcare Care Bundles Program.
Centene on Track With Inorganic Strategies to Aid Growth
by Zacks Equity Research
A number of successful acquisitions over the years should aid Centene's (CNC) overall growth.
Why Investing in Centene Makes Sense for Portfolio Boost
by Zacks Equity Research
Centene (CNC) holds great potential for investment on the back of its growing revenue reserve and a solid inorganic growth story.
MOH vs. JYNT: Which Stock Is the Better Value Option?
by Zacks Equity Research
MOH vs. JYNT: Which Stock Is the Better Value Option?
5 Stocks to Prepare for a Global Economic Slowdown
by Swarup Gupta
In such an event, demand for products and services generated by utilities, consumer staples and medical companies remain invariant.
Centene Vs. Anthem: Which Stock is Better Ahead of Earnings?
by Zacks Equity Research
Centene and Anthem, two dominant players in the health insurance space, are set to gain in an expanding industry. We will see here which one is better placed ahead of earnings.
Is Molina (MOH) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Molina (MOH) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Molina (MOH) closed at $145.28, marking a +0.14% move from the previous day.
Aging Demography, Consolidation Brighten HMO Industry Outlook
by Sapna Bagaria
Increasing retirement population, industry consolidation, growth of ancillary business and easing of regulatory changes promise solid growth for the HMO industry.
Centene Unit Wins Medicaid Contract to Offer Better Care
by Zacks Equity Research
Centene (CNC) arm NH Healthy Families secures Medicaid contract to provide members with better health care.
Centene (CNC) Inks Deal to Acquire WellCare Health for $17.3B
by Zacks Equity Research
Centene (CNC) to buy WellCare for a total consideration of $17.3 billion to form a leader in the government-sponsored healthcare space.
MOH vs. JYNT: Which Stock Is the Better Value Option?
by Zacks Equity Research
MOH vs. JYNT: Which Stock Is the Better Value Option?
Molina (MOH) Stock Moves -1.06%: What You Should Know
by Zacks Equity Research
Molina (MOH) closed at $146.72 in the latest trading session, marking a -1.06% move from the prior day.
Is Molina (MOH) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
WellCare Health Arm MeridianRx Unveils Mobile Application
by Zacks Equity Research
WellCare Health (WCG) unit introduces a unique mobile app, Atlas Compass, to assist PBM members to manage their pharmacy health information.
Has Molina Healthcare (MOH) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (MOH) Outperforming Other Medical Stocks This Year?
Molina (MOH) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Molina (MOH) closed at $140.13, marking a -1.16% move from the previous day.
4 HMO Q4 Outperformers Likely to Retain Beat Streak in Q1
by Srijita Guha
Based on a few key factors, we zero in on four HMO stocks that are set to retain the bull run in first-quarter 2019.
Is Molina Healthcare (MOH) a Good Pick For Value Investors?
by Zacks Equity Research
Molina Healthcare (MOH) stock may be a good choice for value-oriented investors right now from multiple angles.
Molina (MOH) Up 7.4% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Molina (MOH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Magellan Health Down Nearly 40%, in a Year: What's Next?
by Zacks Equity Research
Stiff competition and subdued profitability is weighing on shares of Magellan Health (MGLN).